Andrea Heinz

Dr. Andrea Heinz

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 May 2020 in Critical Reviews in Biochemistry and Molecular Biology
Verified
Journal Article
Open access
AHAndrea Heinz
Andrea Heinz
Elastin is an important protein of the extracellular matrix of higher vertebrates, which confers elasticity and resilience to various tissues and organs including lungs, skin, large blood vessels and ligaments. Owing to its unique structure, extensive cross-linking and durability, it does not undergo significant turnover in healthy tissues and has a half-life of more than 70 years. Elastin is not only a structural protein, influencing the architecture and biomechanical properties of the extracellular matrix, but also plays a vital role in various physiological processes. Bioactive elastin peptides termed elastokines – in particular those of the GXXPG motif – occur as a result of proteolytic degradation of elastin and its non-cross-linked precursor tropoelastin and display several biological activities. For instance, they promote angiogenesis or stimulate cell adhesion, chemotaxis, proliferation, protease activation and apoptosis. Elastin-degrading enzymes such as matrix metalloproteinases, serine proteases and cysteine proteases slowly damage elastin over the lifetime of an organism. The destruction of elastin and the biological processes triggered by elastokines favor the development and progression of various pathological conditions including emphysema, chronic obstructive pulmonary disease, atherosclerosis, metabolic syndrome and cancer. This review gives an overview on types of human elastases and their action on human elastin, including the formation, structure and biological activities of elastokines and their role in common biological processes and severe pathological conditions.

1 March 2021 in Ageing Research Reviews
Verified
Journal Article
Open access
AHAndrea Heinz
Andrea Heinz
Elastic fibers are essential constituents of the extracellular matrix of higher vertebrates and endow several tissues and organs including lungs, skin and blood vessels with elasticity and resilience. During the human lifespan, elastic fibers are exposed to a variety of enzymatic, chemical and biophysical influences, and accumulate damage due to their low turnover. Aging of elastin and elastic fibers involves enzymatic degradation, oxidative damage, glycation, calcification, aspartic acid racemization, binding of lipids and lipid peroxidation products, carbamylation and mechanical fatigue. These processes can trigger an impairment or loss of elastic fiber function and are associated with severe pathologies. There are different inherited or acquired pathological conditions, which influence the structure and function of elastic fibers and microfibrils predominantly in the cardiorespiratory system and skin. Inherited elastic-fiber pathologies have a direct or indirect impact on elastic-fiber formation due to mutations in the fibrillin genes (fibrillinopathies), in the elastin gene (elastinopathies) or in genes encoding proteins that are associated with microfibrils or elastic fibers. Acquired elastic-fiber pathologies appear age-related or as a result of multiple factors impairing tissue homeostasis. This review gives an overview on the fate of elastic fibers over the human lifespan in health and disease.

1 January 2009 in European Journal of Pharmaceutics and Biopharmaceutics
Verified
Journal Article
Closed access
MSM Savolainen
M Savolainen
KKK Kogermann
K Kogermann
AHAndrea Heinz
Andrea Heinz
JAJ Aaltonen
J Aaltonen
LPL Peltonen
L Peltonen
JYJ Yliruusi
J Yliruusi

18 October 2013 in Diabetes
Verified
Journal Article
Open access
PDF file
Sébastien BlaiseSébastien Blaise
Sébastien Blaise
BRBéatrice Romier
Béatrice Romier
CKCharlotte Kawecki
Charlotte Kawecki
MGMaxime Ghirardi
Maxime Ghirardi
FRFanja Rabenoelina
Fanja Rabenoelina
VDVincent Durlach
Vincent Durlach
Although it has long been established that the extracellular matrix acts as a mechanical support, its degradation products, which mainly accumulate during aging, have also been demonstrated to play an important role in cell physiology and the development of cardiovascular and metabolic diseases. In the current study, we show that elastin-derived peptides (EDPs) may be involved in the development of insulin resistance (IRES) in mice. In chow-fed mice, acute or chronic intravenous injections of EDPs induced hyperglycemic effects associated with glucose uptake reduction and IRES in skeletal muscle, liver, and adipose tissue. Based on in vivo, in vitro, and in silico approaches, we propose that this IRES is due to interaction between the insulin receptor (IR) and the neuraminidase-1 subunit of the elastin receptor complex triggered by EDPs. This interplay was correlated with decreased sialic acid levels on the β-chain of the IR and reduction of IR signaling. In conclusion, this is the first study to demonstrate that EDPs, which mainly accumulate with aging, may be involved in the insidious development of IRES.

1 September 2016 in Biochimie
Verified
Journal Article
Closed access
AHAngela C. Mora Huertas
Angela C. Mora Huertas
CSChristian E.H. Schmelzer
Christian E.H. Schmelzer
WHWolfgang Hoehenwarter
Wolfgang Hoehenwarter
FHFrank Heyroth
Frank Heyroth
AHAndrea Heinz
Andrea Heinz

1 November 2007 in European Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
AHAndrea Heinz
Andrea Heinz
MSMarja Savolainen
Marja Savolainen
TRThomas Rades
Thomas Rades
CSClare Strachan
Clare Strachan